Fig. 1From: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis Diagram of study patients. ECOG-PS, Eastern Cooperative Oncology Group performance status; ICI, immune checkpoint inhibitor; NSCLC, non-small cell lung cancer; PD-L1, programmed death ligand-1; TPS, tumor proportion scoreBack to article page